✦ LIBER ✦

SGLT2 inhibitors race to enter type-2 diabetes market

✍ Scribed by Sheridan, Cormac

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Canagliflozin: SGLT2 inhibitor for treat

✍ Donnelly, Richard 📂 Article 📅 2013 🏛 Wiley (John Wiley & Sons) ⚖ 229 KB

SGLT2 versus DPP4 inhibitors for type 2

✍ Scheen, André J 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 53 KB

Clinical implication of SGLT2 inhibitors

✍ Kim, Go Woon; Chung, Sung Hyun 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 629 KB

SGLT-2 inhibitors as second-line therapy

✍ Tahrani, Abd A 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 120 KB

Trial watch: SGLT2 inhibitor shows promi

📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 145 KB

Evaluating SGLT2 inhibitors for type 2 d

✍ Scheen, André J 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 427 KB